Loading...

Robert M Elashoff

Title(s)Professor, Computational Medicine
SchoolMedicine
Address612 Charles E. Young Drive, Ea 5303
Los Angeles CA 90024
Phone59421, 69004
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    MOCSLID-DCC
    NIH/NHLBI R01HL089901Sep 18, 2008 - Jul 31, 2014
    Role: Principal Investigator
    SCLERODERMA LUNG STUDY
    NIH/NHLBI U01HL060606Aug 10, 1999 - Jun 30, 2007
    Role: Principal Investigator
    LOW FAT DIET IN WOMEN WITH STAGE II BREAST CANCER
    NIH/NCI U01CA037583Jul 1, 1984 - Apr 30, 1986
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Using Transitional Changes on High-Resolution Computed Tomography to Monitor the Impact of Cyclophosphamide or Mycophenolate Mofetil on Systemic Sclerosis-Related Interstitial Lung Disease. Arthritis Rheumatol. 2020 02; 72(2):316-325. Kim GHJ, Tashkin DP, Lo P, Brown MS, Volkmann ER, Gjertson DW, Khanna D, Elashoff RM, Tseng CH, Roth MD, Goldin JG. PMID: 31430058.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Cyclophosphamide for Systemic Sclerosis-related Interstitial Lung Disease: A Comparison of Scleroderma Lung Study I and II. J Rheumatol. 2019 10; 46(10):1316-1325. Volkmann ER, Tashkin DP, Sim M, Li N, Khanna D, Roth MD, Clements PJ, Hoffmann-Vold AM, Furst DE, Kim G, Goldin J, Elashoff RM. PMID: 30770517.
      View in: PubMed   Mentions: 2     Fields:    
    3. Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohorts. Ann Rheum Dis. 2019 01; 78(1):122-130. Volkmann ER, Tashkin DP, Sim M, Li N, Goldmuntz E, Keyes-Elstein L, Pinckney A, Furst DE, Clements PJ, Khanna D, Steen V, Schraufnagel DE, Arami S, Hsu V, Roth MD, Elashoff RM, Sullivan KM. PMID: 30409830.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    4. A Cluster-Randomized Trial of Blood-Pressure Reduction in Black Barbershops. N Engl J Med. 2018 Apr 05; 378(14):1291-1301. Victor RG, Lynch K, Li N, Blyler C, Muhammad E, Handler J, Brettler J, Rashid M, Hsu B, Foxx-Drew D, Moy N, Reid AE, Elashoff RM. PMID: 29527973.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    5. Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma. N Engl J Med. 2017 06 08; 376(23):2211-2222. Faries MB, Thompson JF, Cochran AJ, Andtbacka RH, Mozzillo N, Zager JS, Jahkola T, Bowles TL, Testori A, Beitsch PD, Hoekstra HJ, Moncrieff M, Ingvar C, Wouters MWJM, Sabel MS, Levine EA, Agnese D, Henderson M, Dummer R, Rossi CR, Neves RI, Trocha SD, Wright F, Byrd DR, Matter M, Hsueh E, MacKenzie-Ross A, Johnson DB, Terheyden P, Berger AC, Huston TL, Wayne JD, Smithers BM, Neuman HB, Schneebaum S, Gershenwald JE, Ariyan CE, Desai DC, Jacobs L, McMasters KM, Gesierich A, Hersey P, Bines SD, Kane JM, Barth RJ, McKinnon G, Farma JM, Schultz E, Vidal-Sicart S, Hoefer RA, Lewis JM, Scheri R, Kelley MC, Nieweg OE, Noyes RD, Hoon DSB, Wang HJ, Elashoff DA, Elashoff RM. PMID: 28591523.
      View in: PubMed   Mentions: 66     Fields:    Translation:HumansCTClinical Trials
    6. Human TERT promoter mutation enables survival advantage from MGMT promoter methylation in IDH1 wild-type primary glioblastoma treated by standard chemoradiotherapy. Neuro Oncol. 2017 03 01; 19(3):394-404. Nguyen HN, Lie A, Li T, Chowdhury R, Liu F, Ozer B, Wei B, Green RM, Ellingson BM, Wang HJ, Elashoff R, Liau LM, Yong WH, Nghiemphu PL, Cloughesy T, Lai A. PMID: 27571882.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    7. Changes in plasma CXCL4 levels are associated with improvements in lung function in patients receiving immunosuppressive therapy for systemic sclerosis-related interstitial lung disease. Arthritis Res Ther. 2016 12 30; 18(1):305. Volkmann ER, Tashkin DP, Roth MD, Clements PJ, Khanna D, Furst DE, Mayes M, Charles J, Tseng CH, Elashoff RM, Assassi S. PMID: 28038680.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    8. Disability-Specific Atlases of Gray Matter Loss in Relapsing-Remitting Multiple Sclerosis. JAMA Neurol. 2016 Aug 01; 73(8):944-53. MacKenzie-Graham A, Kurth F, Itoh Y, Wang HJ, Montag MJ, Elashoff R, Voskuhl RR. PMID: 27294295.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    9. Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial. Lancet Respir Med. 2016 09; 4(9):708-719. Tashkin DP, Roth MD, Clements PJ, Furst DE, Khanna D, Kleerup EC, Goldin J, Arriola E, Volkmann ER, Kafaja S, Silver R, Steen V, Strange C, Wise R, Wigley F, Mayes M, Riley DJ, Hussain S, Assassi S, Hsu VM, Patel B, Phillips K, Martinez F, Golden J, Connolly MK, Varga J, Dematte J, Hinchcliff ME, Fischer A, Swigris J, Meehan R, Theodore A, Simms R, Volkov S, Schraufnagel DE, Scholand MB, Frech T, Molitor JA, Highland K, Read CA, Fritzler MJ, Kim GHJ, Tseng CH, Elashoff RM. PMID: 27469583.
      View in: PubMed   Mentions: 64     Fields:    Translation:Humans
    10. Why use sex hormones in relapsing-remitting multiple sclerosis? - Authors' reply. Lancet Neurol. 2016 07; 15(8):790-791. Voskuhl R, Wang H, Elashoff RM. PMID: 27302354.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    11. Transitions to different patterns of interstitial lung disease in scleroderma with and without treatment. Ann Rheum Dis. 2016 Jul; 75(7):1367-71. Kim HJ, Tashkin DP, Gjertson DW, Brown MS, Kleerup E, Chong S, Belperio JA, Roth MD, Abtin F, Elashoff R, Tseng CH, Khanna D, Goldin JG. PMID: 26757749.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    12. Development of a Composite Outcome Measure for Systemic Sclerosis Related Interstitial Lung Disease. Rheumatology (Sunnyvale). 2015 Jun; 5(2). Volkmann ER, Tashkin DP, Li N, Furst DE, Clements PJ, Elashoff RM. PMID: 28856069.
      View in: PubMed   Mentions:
    13. Clinical Trials in Non-Small Cell Lung Cancer with Biomarker-Driven Treatment Allocation: Ready or Not, Here We Come. Crit Rev Oncog. 2015; 20(5-6):339-47. Garon EB, Abarca PA, Strunck JL, Nameth D, Neumann C, Wolf B, Kim KY, Marx C, Elashoff RM. PMID: 27279233.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    14. Online self-report data for duchenne muscular dystrophy confirms natural history and can be used to assess for therapeutic benefits. PLoS Curr. 2014 Oct 17; 6. Wang RT, Silverstein Fadlon CA, Ulm JW, Jankovic I, Eskin A, Lu A, Rangel Miller V, Cantor RM, Li N, Elashoff R, Martin AS, Peay HL, Halnon N, Nelson SF. PMID: 25635234.
      View in: PubMed   Mentions:
    15. Lack of FGF23 response to acute changes in serum calcium and PTH in humans. J Clin Endocrinol Metab. 2014 Oct; 99(10):E1951-6. Wesseling-Perry K, Wang H, Elashoff R, Gales B, Jüppner H, Salusky IB. PMID: 25062462.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    16. PDE5 inhibition alleviates functional muscle ischemia in boys with Duchenne muscular dystrophy. Neurology. 2014 Jun 10; 82(23):2085-91. Nelson MD, Rader F, Tang X, Tavyev J, Nelson SF, Miceli MC, Elashoff RM, Sweeney HL, Victor RG. PMID: 24808022.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    17. Deferred use of bevacizumab for recurrent glioblastoma is not associated with diminished efficacy. Neuro Oncol. 2014 Jun; 16(6):815-22. Piccioni DE, Selfridge J, Mody RR, Chowdhury R, Li S, Lalezari S, Wawrzynski J, Quan J, Zurayk M, Chou AP, Sanchez DE, Liau LM, Ellingson BM, Pope WB, Nghiemphu PL, Green RM, Wang HJ, Yong WH, Elashoff R, Cloughesy TF, Lai A. PMID: 24627236.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    18. Annual rates of change in pre- vs. post-bronchodilator FEV1 and FVC over 4 years in moderate to very severe COPD. Respir Med. 2013 Dec; 107(12):1904-11. Tashkin DP, Li N, Halpin D, Kleerup E, Decramer M, Celli B, Elashoff R. PMID: 23972968.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    19. The skeletal consequences of growth hormone therapy in dialyzed children: a randomized trial. Clin J Am Soc Nephrol. 2013 May; 8(5):824-32. Bacchetta J, Wesseling-Perry K, Kuizon B, Pereira RC, Gales B, Wang HJ, Elashoff R, Salusky IB. PMID: 23559676.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    20. Interaction between Pseudomonas and CXC chemokines increases risk of bronchiolitis obliterans syndrome and death in lung transplantation. Am J Respir Crit Care Med. 2013 Mar 01; 187(5):518-26. Gregson AL, Wang X, Weigt SS, Palchevskiy V, Lynch JP, Ross DJ, Kubak BM, Saggar R, Fishbein MC, Ardehali A, Li G, Elashoff R, Belperio JA. PMID: 23328531.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    21. Combined analysis of O6-methylguanine-DNA methyltransferase protein expression and promoter methylation provides optimized prognostication of glioblastoma outcome. Neuro Oncol. 2013 Mar; 15(3):370-81. Lalezari S, Chou AP, Tran A, Solis OE, Khanlou N, Chen W, Li S, Carrillo JA, Chowdhury R, Selfridge J, Sanchez DE, Wilson RW, Zurayk M, Lalezari J, Lou JJ, Ormiston L, Ancheta K, Hanna R, Miller P, Piccioni D, Ellingson BM, Buchanan C, Mischel PS, Nghiemphu PL, Green R, Wang HJ, Pope WB, Liau LM, Elashoff RM, Cloughesy TF, Yong WH, Lai A. PMID: 23328811.
      View in: PubMed   Mentions: 39     Fields:    Translation:HumansCells
    22. An exploration of fixed and random effects selection for longitudinal binary outcomes in the presence of nonignorable dropout. Biom J. 2013 Jan; 55(1):17-37. Li N, Daniels MJ, Li G, Elashoff RM. PMID: 23124889.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    23. Longitudinal data analysis with non-ignorable missing data. Stat Methods Med Res. 2016 Feb; 25(1):205-20. Tseng CH, Elashoff R, Li N, Li G. PMID: 22637472.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    24. Nonparametric inference for assessing treatment efficacy in randomized clinical trials with a time-to-event outcome and all-or-none compliance. Biometrika. 2012 Jun; 99(2):393-404. Elashoff RM, Li G, Zhou Y. PMID: 23843664.
      View in: PubMed   Mentions: 1     Fields:    
    25. Early skeletal and biochemical alterations in pediatric chronic kidney disease. Clin J Am Soc Nephrol. 2012 Jan; 7(1):146-52. Wesseling-Perry K, Pereira RC, Tseng CH, Elashoff R, Zaritsky JJ, Yadin O, Sahney S, Gales B, Jüppner H, Salusky IB. PMID: 22052943.
      View in: PubMed   Mentions: 54     Fields:    Translation:Humans
    26. Predicting treatment outcomes and responder subsets in scleroderma-related interstitial lung disease. Arthritis Rheum. 2011 Sep; 63(9):2797-808. Roth MD, Tseng CH, Clements PJ, Furst DE, Tashkin DP, Goldin JG, Khanna D, Kleerup EC, Li N, Elashoff D, Elashoff RM. PMID: 21547897.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    27. Non-tuberculous mycobacterium infection after lung transplantation is associated with increased mortality. J Heart Lung Transplant. 2011 Jul; 30(7):790-8. Huang HC, Weigt SS, Derhovanessian A, Palchevskiy V, Ardehali A, Saggar R, Saggar R, Kubak B, Gregson A, Ross DJ, Lynch JP, Elashoff R, Belperio JA. PMID: 21482148.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    28. Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies. Gastroenterology. 2011 Jul; 141(1):150-6. Elashoff M, Matveyenko AV, Gier B, Elashoff R, Butler PC. PMID: 21334333.
      View in: PubMed   Mentions: 180     Fields:    Translation:Humans
    29. Phase II study of bevacizumab plus temozolomide during and after radiation therapy for patients with newly diagnosed glioblastoma multiforme. J Clin Oncol. 2011 Jan 10; 29(2):142-8. Lai A, Tran A, Nghiemphu PL, Pope WB, Solis OE, Selch M, Filka E, Yong WH, Mischel PS, Liau LM, Phuphanich S, Black K, Peak S, Green RM, Spier CE, Kolevska T, Polikoff J, Fehrenbacher L, Elashoff R, Cloughesy T. PMID: 21135282.
      View in: PubMed   Mentions: 180     Fields:    Translation:HumansCTClinical Trials
    30. A method to estimate treatment efficacy among latent subgroups of a randomized clinical trial. Stat Med. 2011 Mar 30; 30(7):709-17. Altstein LL, Li G, Elashoff RM. PMID: 21394747.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    31. Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidism. Kidney Int. 2011 Jan; 79(1):112-9. Wesseling-Perry K, Pereira RC, Sahney S, Gales B, Wang HJ, Elashoff R, Jüppner H, Salusky IB. PMID: 20861820.
      View in: PubMed   Mentions: 60     Fields:    Translation:Humans
    32. Differential response of triple-negative breast cancer to a docetaxel and carboplatin-based neoadjuvant treatment. Cancer. 2010 Sep 15; 116(18):4227-37. Chang HR, Glaspy J, Allison MA, Kass FC, Elashoff R, Chung DU, Gornbein J. PMID: 20549829.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    33. Value of the new bone classification system in pediatric renal osteodystrophy. Clin J Am Soc Nephrol. 2010 Oct; 5(10):1860-6. Bakkaloglu SA, Wesseling-Perry K, Pereira RC, Gales B, Wang HJ, Elashoff RM, Salusky IB. PMID: 20634327.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    34. Systemic sclerosis-associated interstitial lung disease-proposed recommendations for future randomized clinical trials. Clin Exp Rheumatol. 2010 Mar-Apr; 28(2 Suppl 58):S55-62. Khanna D, Brown KK, Clements PJ, Elashoff R, Furst DE, Goldin J, Seibold JR, Silver RM, Tashkin DP, Wells AU. PMID: 20576216.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    35. The calcemic response to continuous parathyroid hormone (PTH)(1-34) infusion in end-stage kidney disease varies according to bone turnover: a potential role for PTH(7-84). J Clin Endocrinol Metab. 2010 Jun; 95(6):2772-80. Wesseling-Perry K, Harkins GC, Wang HJ, Elashoff R, Gales B, Horwitz MJ, Stewart AF, Jüppner H, Salusky IB. PMID: 20382692.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    36. International randomized clinical trial, stroke inpatient rehabilitation with reinforcement of walking speed (SIRROWS), improves outcomes. Neurorehabil Neural Repair. 2010 Mar-Apr; 24(3):235-42. Dobkin BH, Plummer-D'Amato P, Elashoff R, Lee J. PMID: 20164411.
      View in: PubMed   Mentions: 31     Fields:    Translation:HumansCTClinical Trials
    37. Treatment of scleroderma-interstitial lung disease with cyclophosphamide is associated with less progressive fibrosis on serial thoracic high-resolution CT scan than placebo: findings from the scleroderma lung study. Chest. 2009 Nov; 136(5):1333-1340. Goldin J, Elashoff R, Kim HJ, Yan X, Lynch D, Strollo D, Roth MD, Clements P, Furst DE, Khanna D, Vasunilashorn S, Li G, Tashkin DP. PMID: 19892673.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    38. Minimally important differences in the Mahler's Transition Dyspnoea Index in a large randomized controlled trial--results from the Scleroderma Lung Study. Rheumatology (Oxford). 2009 Dec; 48(12):1537-40. Khanna D, Tseng CH, Furst DE, Clements PJ, Elashoff R, Roth M, Elashoff D, Tashkin DP. PMID: 19776222.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    39. Relationship between plasma fibroblast growth factor-23 concentration and bone mineralization in children with renal failure on peritoneal dialysis. J Clin Endocrinol Metab. 2009 Feb; 94(2):511-7. Wesseling-Perry K, Pereira RC, Wang H, Elashoff RM, Sahney S, Gales B, Jüppner H, Salusky IB. PMID: 19050056.
      View in: PubMed   Mentions: 60     Fields:    Translation:Humans
    40. Classification of parenchymal abnormality in scleroderma lung using a novel approach to denoise images collected via a multicenter study. Acad Radiol. 2008 Aug; 15(8):1004-16. Kim HJ, Li G, Gjertson D, Elashoff R, Shah SK, Ochs R, Vasunilashorn F, Abtin F, Brown MS, Goldin JG. PMID: 18620121.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    41. Elevated stress-hemoconcentration in major depression is normalized by antidepressant treatment: secondary analysis from a randomized, double-blind clinical trial and relevance to cardiovascular disease risk. PLoS One. 2008; 3(7):e2350. Wong ML, Dong C, Esposito K, Thakur S, Liu W, Elashoff RM, Licinio J. PMID: 18985146.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    42. Image-guided endoscopic evacuation of spontaneous intracerebral hemorrhage. Surg Neurol. 2008 May; 69(5):441-6; discussion 446. Miller CM, Vespa P, Saver JL, Kidwell CS, Carmichael ST, Alger J, Frazee J, Starkman S, Liebeskind D, Nenov V, Elashoff R, Martin N. PMID: 18424298.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCTClinical Trials
    43. A joint model for longitudinal measurements and survival data in the presence of multiple failure types. Biometrics. 2008 Sep; 64(3):762-71. Elashoff RM, Li G, Li N. PMID: 18162112.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    44. Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease. Am J Respir Crit Care Med. 2007 Nov 15; 176(10):1026-34. Tashkin DP, Elashoff R, Clements PJ, Roth MD, Furst DE, Silver RM, Goldin J, Arriola E, Strange C, Bolster MB, Seibold JR, Riley DJ, Hsu VM, Varga J, Schraufnagel D, Theodore A, Simms R, Wise R, Wigley F, White B, Steen V, Read C, Mayes M, Parsley E, Mubarak K, Connolly MK, Golden J, Olman M, Fessler B, Rothfield N, Metersky M, Khanna D, Li N, Li G. PMID: 17717203.
      View in: PubMed   Mentions: 85     Fields:    Translation:Humans
    45. An approach to joint analysis of longitudinal measurements and competing risks failure time data. Stat Med. 2007 Jun 30; 26(14):2813-35. Elashoff RM, Li G, Li N. PMID: 17124698.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    46. Predicting a change in diagnosis from ulcerative colitis to Crohn's disease: a nested, case-control study. Clin Gastroenterol Hepatol. 2007 May; 5(5):602-8; quiz 525. Melmed GY, Elashoff R, Chen GC, Nastaskin I, Papadakis KA, Vasiliauskas EA, Liu W, Landers C, Ippoliti AF, Targan SR. PMID: 17478347.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    47. Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer. Clin Cancer Res. 2006 Jul 01; 12(13):4018-26. Pantuck AJ, Leppert JT, Zomorodian N, Aronson W, Hong J, Barnard RJ, Seeram N, Liker H, Wang H, Elashoff R, Heber D, Aviram M, Ignarro L, Belldegrun A. PMID: 16818701.
      View in: PubMed   Mentions: 86     Fields:    Translation:HumansAnimalsCellsCTClinical Trials
    48. Reliability and validity of bilateral thigh and foot accelerometry measures of walking in healthy and hemiparetic subjects. Neurorehabil Neural Repair. 2006 Jun; 20(2):297-305. Saremi K, Marehbian J, Yan X, Regnaux JP, Elashoff R, Bussel B, Dobkin BH. PMID: 16679506.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    49. A phase I trial to determine the optimal biological dose of celecoxib when combined with erlotinib in advanced non-small cell lung cancer. Clin Cancer Res. 2006 Jun 01; 12(11 Pt 1):3381-8. Reckamp KL, Krysan K, Morrow JD, Milne GL, Newman RA, Tucker C, Elashoff RM, Dubinett SM, Figlin RA. PMID: 16740761.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCTClinical Trials
    50. Prediction of metastatic melanoma in nonsentinel nodes and clinical outcome based on the primary melanoma and the sentinel node. Mod Pathol. 2004 Jul; 17(7):747-55. Cochran AJ, Wen DR, Huang RR, Wang HJ, Elashoff R, Morton DL. PMID: 15098011.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    51. Regional differences in bronchoalveolar lavage and thoracic high-resolution computed tomography results in dyspneic patients with systemic sclerosis. Arthritis Rheum. 2004 Jun; 50(6):1909-17. Clements PJ, Goldin JG, Kleerup EC, Furst DE, Elashoff RM, Tashkin DP, Roth MD. PMID: 15188367.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    52. Coronary vasomotor abnormalities in insulin-resistant individuals. Ann Intern Med. 2004 May 04; 140(9):700-8. Quiñones MJ, Hernandez-Pampaloni M, Schelbert H, Bulnes-Enriquez I, Jimenez X, Hernandez G, De La Rosa R, Chon Y, Yang H, Nicholas SB, Modilevsky T, Yu K, Van Herle K, Castellani LW, Elashoff R, Hsueh WA. PMID: 15126253.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCTClinical Trials
    53. A pilot clinical study of short-term isoflavone supplements in breast cancer patients. Nutr Cancer. 2004; 49(1):59-65. Sartippour MR, Rao JY, Apple S, Wu D, Henning S, Wang H, Elashoff R, Rubio R, Heber D, Brooks MN. PMID: 15456636.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimals
    54. Sevelamer hydrochloride: an effective phosphate binder in dialyzed children. Pediatr Nephrol. 2003 Dec; 18(12):1260-4. Mahdavi H, Kuizon BD, Gales B, Wang HJ, Elashoff RM, Salusky IB. PMID: 14586677.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    55. The use of oxytocin in nipple fluid aspiration. Breast J. 2003 Jul-Aug; 9(4):266-8. Zhang L, Shao ZM, Beatty P, Sartippour M, Wang HJ, Elashoff R, Chang H, Brooks MN. PMID: 12846857.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCTClinical Trials
    56. Inhibition of fibroblast growth factors by green tea. Int J Oncol. 2002 Sep; 21(3):487-91. Sartippour MR, Heber D, Zhang L, Beatty P, Elashoff D, Elashoff R, Go VL, Brooks MN. PMID: 12168090.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    Robert's Networks
    Concepts (342)
    Derived automatically from this person's publications.
    _
    Co-Authors (43)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _